SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Onconetix, Inc. (ONCO) has a negative trailing P/E of -0.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -179.65%.
Criteria proven by this page:
- VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.6); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -179.65%).
- Trailing Earnings Yield -179.65% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
Overall SharesGrow Score: 31/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ONCO
Valuation Multiples
P/E (TTM)-0.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.50
P/S Ratio10.00
EV/EBITDA-0.1
Per Share Data
EPS (TTM)$-4.28
Book Value / Share$4.80
Revenue / Share$0.25
FCF / Share$-2.95
Yields & Fair Value
Earnings Yield-179.65%
Dividend Yield0.00%
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-13,500.6 |
0.00 |
1,849.88 |
0.00 |
- |
| 2020 |
-6,937.5 |
-78.68 |
2,344.07 |
0.00 |
- |
| 2021 |
-3,247.1 |
-26.74 |
7,670.74 |
0.00 |
- |
| 2022 |
-17.6 |
-0.07 |
10.55 |
0.00 |
- |
| 2023 |
-1.6 |
0.00 |
-10.58 |
1,013.97 |
- |
| 2024 |
-0.5 |
0.00 |
3.15 |
11.99 |
0.68% |
| 2025 |
-1.8 |
0.02 |
1.62 |
31.40 |
1.60% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.07 |
$0.00 |
$-821.92K |
- |
| 2020 |
$-0.14 |
$0.00 |
$-1.6M |
- |
| 2021 |
$-0.31 |
$0.00 |
$-3.42M |
- |
| 2022 |
$-1.09 |
$0.00 |
$-13.42M |
- |
| 2023 |
$-87.60 |
$58.47K |
$-37.41M |
-63986.5% |
| 2024 |
$-520.93 |
$2.52M |
$-58.69M |
-2325.2% |
| 2025 |
$-4.73 |
$815.37K |
$-14.03M |
-1721% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-20,060.00 |
$-20,060.00 – $-20,060.00 |
$881.22K |
$881.22K – $881.22K |
1 |
| 2027 |
$-21,420.00 |
$-21,420.00 – $-21,420.00 |
$952.38K |
$952.38K – $952.38K |
1 |
